Disease Modifying Genes in Severe Asthma
This trial is active, not recruiting.
|Sponsor||New York University School of Medicine|
|Start date||April 2002|
|End date||January 2017|
|Trial size||2000 participants|
|Trial identifier||NCT00212537, H9698|
Gene and protein bank to study disease modifying and susceptibility genes and proteins in urban patients with asthma.
|Observational model||case control|
To recruit and characterize a cohort of subjects with asthma who reside in a high pollution, high asthma risk neighborhood
time frame: five yeARS
Male or female participants at least 18 years old.
- Ages 18 and above
- Greater than 10 pack year tobacco history
- Lung diseases other than asthma
|Official title||Disease Modifying Genes in Severe Asthma|
|Principal investigator||Joan Reibman, MD|
Call for more information